Thousands of Missourians with mental health disabilities are unnecessarily trapped in nursing homes against their will because of systemic failures by the state, according to a scalding report from the Department of Justice.
Jun 19, 2024
0
2
The U.S. Food and Drug Administration announced Monday that it has joined up with the Department of Justice and several other federal agencies to do more to stop the sale of illegal e-cigarettes in this country.
Jun 11, 2024
0
0
Early in the morning of Feb. 21, Change Healthcare, a company unknown to most Americans that plays a huge role in the U.S. health system, issued a brief statement saying some of its applications were "currently unavailable."
Mar 4, 2024
0
2
The US Justice Department urged an appeals court on Monday to freeze a ruling by a federal judge in Texas that would ban a widely used abortion pill in a far-reaching case that looks likely to wind up at the Supreme Court.
Apr 10, 2023
0
0
People with intellectual and developmental disabilities experience sexual assault, abuse, violence and are victims of crime at exponentially higher rates than the typically developing population. Yet there are few abuse prevention ...
Jan 29, 2021
0
6
Swiss pharmaceutical giant Novartis will pay some $729 million to settle a lawsuit brought by Washington accusing it of paying kickbacks to doctors, among other allegations.
Jul 2, 2020
0
6
The U.S. Department of Justice said Wednesday that Irish drugmaker Shire will pay $56.5 million to settle allegations it broke the law in promoting five different drugs, including its attention deficit disorder drugs Adderall ...
Sep 24, 2014
0
0
British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.
Aug 19, 2014
0
0
President Barack Obama's administration ceded ground Thursday in the US war on drugs, saying it will not dispute the legalization of recreational marijuana in Colorado and Washington state.
Aug 29, 2013
0
0
The U.S. Justice Department said Tuesday that drugmaker Pfizer Inc. will pay almost $491 million to resolve an investigation into illegal marketing of the organ transplant drug Rapamune by a company Pfizer later acquired.
Jul 30, 2013
0
0
